SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 197.62+0.1%Dec 24 12:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Alper H.YUKSEL who wrote (26557)11/17/1998 8:39:00 AM
From: Henry Niman  Read Replies (1) of 32384
 
Bear Stearns came out with a reiterated BUY this morning, keeping the 4Q loss at $0.02 and next year's gain at $0.09. They expect Panretin sales next year to be $14 million and ONTAK sales to be $14.5 million. Panretin sales are expected to grow to the $40-$50 million per year range and ONTAK is projected to eventually produce $30 million in annual sales. The y expect an ex-US, ex-Europe marketing deal for Panretin and ONTAK to be announced soon, possibly this year.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext